metformin and Ambulation Disorders, Neurologic
metformin has been researched along with Ambulation Disorders, Neurologic in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Metformin, the well-known anti-diabetic drug, has been shown recently to improve the grip test performance of the DMSXL mouse model of myotonic dystrophy type 1." | 9.27 | Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. ( Arrouasse, R; Audureau, E; Baghdoyan, S; Bassez, G; Bhugaloo, H; Gourlay-Chu, ML; Hogrel, JY; Le Corvoisier, P; Peschanski, M, 2018) |
"Metformin, the well-known anti-diabetic drug, has been shown recently to improve the grip test performance of the DMSXL mouse model of myotonic dystrophy type 1." | 5.27 | Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. ( Arrouasse, R; Audureau, E; Baghdoyan, S; Bassez, G; Bhugaloo, H; Gourlay-Chu, ML; Hogrel, JY; Le Corvoisier, P; Peschanski, M, 2018) |
"No significant difference in the other treatment groups." | 1.48 | Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia. ( Hamilton, W; Hattersley, AT; Hope, SV; Shields, BM; Taylor, PJ, 2018) |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hope, SV | 1 |
Taylor, PJ | 1 |
Shields, BM | 1 |
Hattersley, AT | 1 |
Hamilton, W | 1 |
Bassez, G | 1 |
Audureau, E | 1 |
Hogrel, JY | 1 |
Arrouasse, R | 1 |
Baghdoyan, S | 1 |
Bhugaloo, H | 1 |
Gourlay-Chu, ML | 1 |
Le Corvoisier, P | 1 |
Peschanski, M | 1 |
Trials
1 trial available for metformin and Ambulation Disorders, Neurologic
Article | Year |
---|---|
Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial.
Topics: Adult; Double-Blind Method; Female; Gait; Gait Disorders, Neurologic; Humans; Hypoglycemic Agents; M | 2018 |
Other Studies
1 other study available for metformin and Ambulation Disorders, Neurologic
Article | Year |
---|---|
Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia.
Topics: Accidental Falls; Age Factors; Aged; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Me | 2018 |